AdvertisementArticle Page Top (728×90)
Back to All Ideas
Consumer·9:07 AM ET · April 24, 2026·3 min read

Carter's (CRI) Trades Near Mid-Range as Analyst Sentiment Turns Cautious

NYSE:CRI

Alpha Stocks Insight Staff

Independent stock news and analysis covering NASDAQ and NYSE markets.

AdvertisementIn-Article Ad (in-article)

CRI shares dipped 2% Thursday as Wall Street sentiment shifted notably bearish. Fundamentals show mixed signals with a forward P/E of 10.6x and thin net margins.

NYSE: CRI · April 24, 2026 · 3 min read

Carter's, Inc. (NYSE: CRI) slipped $0.79, or 2.03%, to close at $38.08 on Thursday, as analyst sentiment around the children's apparel retailer has grown noticeably more cautious heading into the back half of the quarter. The move leaves shares trading in the middle of their 52-week range of $23.38 – $44.44, reflecting an uncertain near-term backdrop for consumer discretionary names.

Financial Snapshot

  • Market capitalisation: $1.4 billion
  • Trailing P/E: 15.1x | Forward P/E: 10.6x
  • Gross margin: 45.4%
  • Operating margin: 8.6%
  • Net margin: 3.2%
  • Revenue growth (YoY): 7.6%
  • Earnings growth (YoY): 4.0%

What the Numbers Suggest

The compression between the trailing and forward P/E — from 15.1x to 10.6x — implies the market is pricing in meaningful earnings improvement ahead, yet the current net margin of 3.2% underscores how little room (NYSE: CRI) has for operational missteps. The gross margin of 45.4% is a relative strength for a specialty retailer, but it is being partially offset by an operating margin of 8.6%, suggesting selling, general, and administrative costs remain a drag on profitability.

Revenue growth of 7.6% year-over-year alongside earnings growth of 4.0% indicates that top-line momentum has not yet fully translated to the bottom line — a dynamic that analysts appear to be weighing carefully. With broader consumer discretionary spending under pressure from cautious household budgets, Carter's exposure to value-conscious parents buying essentials for young children provides some demand stability, though it is not immune to category softness.

Wall Street View

The shift in analyst sentiment over the past month is the most notable development for (NYSE: CRI) watchers. As of April 1, 2026, the consensus stood at 2 Strong Buy, 0 Buy, 4 Hold, 7 Sell, and 1 Strong Sell — a markedly more bearish distribution than the prior month's reading of 1 Strong Buy, 0 Buy, and 4 Hold, with no sell-side ratings reported in March. The addition of seven Sell ratings in a single month represents a significant re-rating of sentiment and may partly explain the pressure on the stock price. No price targets were provided alongside these recommendations.

Investor Takeaway

Carter's presents a nuanced picture: a forward valuation of 10.6x earnings that could appeal to value-oriented investors, offset by a thin 3.2% net margin and a pronounced shift toward bearish analyst recommendations over the past 30 days. Until the company demonstrates that revenue growth is converting more efficiently into net income, or until the analyst community revisits its cautious stance, (NYSE: CRI) is likely to remain range-bound near current levels. Investors should monitor upcoming operational disclosures closely for any signs of margin improvement.

AdvertisementMid-Article Leaderboard (728×90)
Carter'sCRIConsumer DiscretionaryStock Analysis

Important Legal Disclaimer

This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.

Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.